eMedevents
  • 143,047+ Medical Conferences
  • 279 Specialties
  • 10,781 Organizers
  • 153,946 Speakers
  • 156 Countries
  • 4,640 Cities
47,682+
CME Conference Registrations Sold
Home  >  Speakers  >  Rakesh Dixit
Rakesh Dixit

Rakesh Dixit

    PhD
Founder, President, Chief Executive Officer, Vice President, Global Head | Gaithersburg, Maryland    United States of America
Toxicology, Clinical Pharmacology
Toxicology, Clinical Pharmacology,...More
Spoken at 15 events
Speaking at 1 event

Biography :

Dr. Dixit conducted extensive graduate and post-graduate training in Toxicology–Biochemistry with both Indian and US Institutions (Case Western Reserve University, Medical College of Ohio, University of Nebraska) and is board certified in Toxicology from the American Board of Toxicology, Inc. since 1992. Rakesh served as a Senior Toxicologist with Midwest Research Institute between 1987 and 1992.

In December 1992, Rakesh joined the Department of Safety Assessment, Merck and Co., Inc, West Point, PA where he served in various management positions. During his about 14 years with Merck, Rakesh contributed to the successful filings of many blockbuster drugs. For about a year, Rakesh was associated with Johnson and Johnson PRD, La Jolla/Alza as Senior Director of Toxicology.

In Aug 2006, Rakesh joined MedImmune, Inc. (an AstraZeneca Biologics company) as Senior Director (R &D) & Global Head of Biologics Safety Assessment, Experimental Pathology, and Laboratory Animal Medicine. In his current position as a Vice President of R &D, Rakesh is responsible for providing guidance on research and development of biological products; including nonclinical toxicology/safety support for all AstraZeneca-MedImmune biologics products, including monoclonal antibodies and vaccines.

**********************
** ***** ********
 
For speaker's contact information - Contact us

Specialties

Toxicology, Clinical Pharmacology

Interested Topics

Toxicology, Clinical Pharmacology, Biochemistry, Drug Development, Biotechnology, Pharmaceutical Industry, Biopharmaceuticals, Regulatory Affairs, Monoclonal Antibodies, Biomarkers

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

Appears with

Close

Send Message